Streetbeat News

Products Services

MRUS

Merus N.V. (NASDAQ:MRUS) has been granted a second Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for its drug zenocutuzumab (Zeno) for the treatment of NRG1+ non-small cell lung cancer. This follows a previous BTD for the treatment of NRG1+ pancreatic cancer. The BTD is supported by data from the ongoing phase 1/2 eNRGy trial and Early Access Program (EAP). Merus plans to engage in expedited discussions with the FDA and provide an update on the path and timeline to a potential Biologics License Application (BLA) submission.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:03 pm

LDOS

Leidos (NYSE:LDOS) has been selected to provide pilot training for U.S. Army aviators transitioning to the High Accuracy Detection, Exploitation System (HADES) program. The company will provide ground and flight training through Bombardier Global 6000-class business jets, with FAA certified flight instructors, curriculum, support materials, and training manuals.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:01 pm

NKLA

Nikola Corporation (NASDAQ:NKLA) has been awarded a $41.9 million grant by the California Transportation Commission (CTC) to build six heavy-duty hydrogen refueling stations across Southern California. The grant is part of the Trade Corridor Enhancement Program (TCEP) and will be used to further Caltrans' zero-emission vehicle (ZEV) strategy. The stations are expected to facilitate refueling for approximately 80 to 100 trucks per station per day and are designed to scale up over time.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:01 pm

BBIO

BMRN

BMO Capital Markets has upgraded BioMarin Pharmaceutical Inc (BMRN) to Outperform from Market Perform, maintaining the price target at $102. The FDA recently approved BioMarin's Roctavian gene therapy for adults with severe hemophilia A. However, the analyst expects Roctavian's uptake to be slower than consensus expectations. The analyst also highlighted the success of Voxzogo's launch in Achondroplasia as a significant growth driver for BioMarin. Meanwhile, recent data from BridgeBio Pharma Inc (BBIO) suggests that Infigratinib can gain significant market share in Achondroplasia.

Portfolio Pulse from Vandana Singh

July 05, 2023 | 7:42 pm

TSLA

Tesla has set a new record for vehicle deliveries in Q2 2023 due to strategic price reductions and increased production. The company's stock price has shown significant recovery with a 30% surge in June and a 135% increase year-to-date. Tesla's Q2 financial results, set to be released on July 19th, have the potential to greatly impact the stock price. The stock closed at $279.82, trading up by 6.79% on July 3.

Portfolio Pulse from Zaheer Anwari

July 05, 2023 | 7:17 pm

AMZN

SPY

Blue Origin, Jeff Bezos' space company, is planning to expand into international markets and is considering a launch site outside the US. The company is also seeking partnerships and acquisitions in Europe and beyond to grow its launch and space services businesses. Europe's imminent retirement of the Ariane 5 rocket and the implosion of Virgin Orbit could provide opportunities for Blue Origin. The company is also considering opportunities in the Middle East. Blue Origin has struggled to compete with Rocket Lab and SpaceX, but is developing a fully reusable heavy-lift orbital rocket called New Glenn.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 7:12 pm

ATVI

MSFT

SONY

Microsoft Corp. (NASDAQ:MSFT) has claimed in a court document that Sony Group Corp. (NYSE:SONY) plans to release a PlayStation 5 Slim later this year, priced at $399.99. The document was released during the ongoing Federal Trade Commission trial over Microsoft's $68.7 billion acquisition of Activision Blizzard Inc (NASDAQ:ATVI). Microsoft is trying to persuade the court that Nintendo Switch should be classified within the same market segment as the Xbox Series consoles and the PlayStation 5. Sony is also expected to release a handheld version of PlayStation 5 later this year for under $300.

Portfolio Pulse from Franca Quarneti

July 05, 2023 | 6:20 pm

XPEV

Shares of XPeng Inc. (NYSE:XPEV) are trading higher following robust vehicle delivery numbers from the EV industry. Other companies such as Tesla, Rivian, and Nio also reported strong delivery numbers. The positive news also impacted the lithium industry, a critical element in EV batteries, causing a rise in lithium stocks.

Portfolio Pulse from Ryan Gustafson

July 05, 2023 | 5:54 pm

SAVA

Cassava Sciences, Inc. (NASDAQ:SAVA) announced the top-line clinical results from its Cognition Maintenance Study where oral simufilam in patients with mild-to-moderate Alzheimer's slowed cognitive decline by 38% over 6 months. Despite the positive results, shares of SAVA were down 14.4% at $21.67.

Portfolio Pulse from Ryan Gustafson

July 05, 2023 | 5:47 pm

TSLA

Tesla Inc's Model Y has become the most sold car in Iceland this year, with 1,316 units registered in the first six months of 2023. This breaks a 35-year-old record for the highest number of a single car model sold in a year. The previous record was held by Toyota Corolla in 1988 with over 1,200 units registered.

Portfolio Pulse from Benzinga EV Insights

July 05, 2023 | 5:08 pm